Skip to content

Oxandrolone

Anavar. Mild anabolic steroid with high anabolic:androgenic ratio. FDA-approved for muscle wasting conditions. Used for body composition and TRT augmentation.

Intelligence Profile

Clinical Applications

Oxandrolone, an anabolic steroid, has been investigated for several clinical applications, though the evidence base varies significantly across different conditions.

Growth Disorders

Clinical trials have examined oxandrolone's role in pediatric growth conditions. A completed Phase 2 study (NCT00001343) investigated hormonal effects in growth hormone-treated girls with Turner syndrome, though specific outcomes are not detailed in the available evidence. Research has also explored androgen therapy effects on final adult height in boys with constitutional delay of growth and puberty, with meta-analysis data suggesting potential benefits for growth outcomes.

Bone Marrow Disorders

A Phase 1 clinical trial (NCT00243399) evaluated oxandrolone for treating bone marrow aplasia in Fanconi anemia patients. This represents investigation into the compound's potential hematopoietic effects, though specific efficacy data from this study is not provided in the available evidence.

Musculoskeletal and Recovery Applications

Several studies have examined oxandrolone in muscle and bone recovery contexts. Research in burn patients has compared oxandrolone to bisphosphonates for treating burn-induced bone loss, suggesting potential therapeutic applications in trauma recovery. A terminated trial (NCT03091075) investigated oxandrolone for rotator cuff conditions, though the reasons for termination and any preliminary findings are not specified.

Clinical research has also explored oxandrolone's role in recovery after critical illness, with studies examining testosterone and anabolic therapy for restoring strength, function, and quality of life in critically ill patients.

Neuromuscular Conditions

A completed study (NCT00027391) investigated combined albuterol and oxandrolone treatment in patients with facioscapulohumeral dystrophy (FSHD), representing exploration of anabolic steroids in genetic muscle disorders. Additionally, research has examined anabolic steroid use for improving function after spinal cord injury (NCT00223769).

Limitations and Considerations

The available evidence shows oxandrolone has been studied across diverse clinical applications, but many trials lack detailed outcome data in the provided evidence. Some studies have noted potential adverse effects, including anxiety-like behaviors and neurochemical changes observed in animal models. The clinical utility appears most established in growth disorders and recovery contexts, though definitive efficacy conclusions require review of complete trial results.

This information is for educational purposes only and should not replace professional medical advice. Consult healthcare providers for treatment decisions.

Free account required

Clinical data requires a free AXIFI account to access clinical data, safety profiles, and research papers.